stars 1 stars 2 stars 3

BCN Peptides is a privately held company focused on the cGMP Industrial Manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. We concentrate in the following activities: GMP Bulk Generic Peptides and Custom Synthesis of proprietary API Peptides. BCN Peptides has an excellent GMP compliance track record: FDA Approved, EDQM Approved and it holds multiple CEPs from European Pharmacopoeia. We manufacture multi-kilo batches of GMP Peptide using SPPS technology: from the R&D, through batches for the Clinical Trials, up to Bulk Commercial Quantities.

BCN Peptides Questions

The BCN Peptides annual revenue was $7 million in 2026.

Berta Ponsati is the CEO of BCN Peptides.

65 people are employed at BCN Peptides.

The NAICS codes for BCN Peptides are [3254, 32541, 32, 325].

The SIC codes for BCN Peptides are [283, 28].

Top BCN Peptides Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Spring 2026 G2 Best Est ROI Mid Market Spring 2026 G2 Easiest Admin Mid Market Spring 2026 G2 Most Implementable Spring 2026 G2 Best Results Mid Market Spring 2026 G2 Lead Capture Mid Market Spring 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users